Lombard Medical, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2016. For the 2016 second quarter global revenue was $3.8 million as compared to $4.5 million in the same prior year period. The net loss $8.3 million, or $0.42 loss per share, compared to a net loss of $8.2 million, or $0.51 loss per share, for the second quarter of 2015. Operating loss was $7.293 million against $8.236 million a year ago. Loss before taxation was $8.525 million against $8.435 million a year ago. For the first six months of 2016, global revenue was $6.7 million as compared to $7.9 million in the prior year period. The year-over-year reduction in revenue is attributable to the redeployment of commercial resources from the US to Europe to support the launch of Altura coupled with delayed stocking orders from the Company’s distribution partner in Japan as it prepares for approval and launch of the IntelliFlex delivery system. For the first six months of 2016, the net loss was $15.9 million, or $0.80 loss per share, compared to $17.7 million, or $1.10 loss per share, for the prior year period. Operating loss was $14.613 million against $17.993 million a year ago. Loss before taxation was $16.336 million against $18.167 million a year ago. Net cash outflow from operating activities was $17.554 million against $14.846 million a year ago. Purchase of property, plant and equipment was $0.249 million against $0.830 million a year ago.